Skip to main content
Top
Published in: BMC Anesthesiology 1/2020

Open Access 01-12-2020 | Breast Surgery | Research article

Increased minimum alveolar concentration-awake of Sevoflurane in women of breast surgery with sleep disorders

Authors: Yuanyuan Cao, Lei Zhang, Xiaohui Peng, Yun Wu, Qunlin Zhang, Erwei Gu, Ye Zhang

Published in: BMC Anesthesiology | Issue 1/2020

Login to get access

Abstract

Background

Sleep disorders are commonly encountered in clinic. Evidences showed that sleep deprivation may modulate the effectiveness of general anesthetics in rats. However, this phenomenon has not been explored in humans. The study aimed to investigate whether the hypnotic potency of sevoflurane in patients with sleep disorders differ from patients with normal sleep habits.

Methods

We recruited 44 patients scheduled for elective breast surgery and eventually analyzed 38 patients, including 19 subjects with normal sleep habits and 19 subjects with sleep disorders. According to the Dixon ‘up-and-down’ design, patients received sevoflurane at preselected concentrations starting at 1.0 vol%. After a steady-state period, a verbal command for testing awakening was performed. Based on the negative or positive response to the verbal command, we decreased or increased the concentration of sevoflurane by 0.2 vol% in the next patient accordingly. Plasma orexin-A was also measured before observation.

Results

The MACawake of sevoflurane was 0.80% [95% confidence interval (CI), 0.683–0.926%] in the sleep disordered group vs 0.60% [95% CI, 0.493–0.689%] in the control group. The relative median potency between groups was 0.750 (95% CI, 0.236–0.969). Patients with sleep disorders had significantly higher orexin-A levels than control (72.17 ± 18.24 vs. 36.16 ± 14.18 pg/mL). A significant, positive relationship was detected between orexin-A level and probability of awakening (OR = 1.081, 95% CI is 1.020–1.146, P = 0.008).

Conclusions

MACawake of sevoflurane is higher in mild-aged women of breast surgery with sleep disorders compared to those with normal sleep habits. The increased anesthetic requirement may be related to changes of orexin-A levels. These findings suggest that sleep may have a potential impact on clinical anesthesia, including changes of sensitivity to anesthetics or postoperative complications. Further research is needed to confirm this hypothesis.

Clinical trial registration

Chinese Clinical Trial Registry (ChiCTR1800016022​), date of registration 07 May 2018.
Appendix
Available only for authorised users
Literature
1.
go back to reference Todd OM, Gelrich L, MacLullich AM, et al. Sleep disruption at home as an independent risk factor for postoperative delirium. J Am Geriatr Soc. 2017;65(5):949–57.CrossRef Todd OM, Gelrich L, MacLullich AM, et al. Sleep disruption at home as an independent risk factor for postoperative delirium. J Am Geriatr Soc. 2017;65(5):949–57.CrossRef
2.
go back to reference Leung JM, Sands LP, Newman S, et al. Preoperative sleep disruption and postoperative delirium. J Clin Sleep Med. 2015;11(8):907–13.CrossRef Leung JM, Sands LP, Newman S, et al. Preoperative sleep disruption and postoperative delirium. J Clin Sleep Med. 2015;11(8):907–13.CrossRef
3.
go back to reference Tung A, Szafran MJ, Bluhm B, et al. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane. Anesthesiol. 2002;97(4):906–11.CrossRef Tung A, Szafran MJ, Bluhm B, et al. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane. Anesthesiol. 2002;97(4):906–11.CrossRef
4.
go back to reference Ran MZ, Wu W, Li JN, et al. Reduction of orexin-a is responsible for prolonged emergence of the rat subjected to sleep deprivation from isoflurane anesthesia. CNS Neurosci Ther. 2015;21(3):298–300.CrossRef Ran MZ, Wu W, Li JN, et al. Reduction of orexin-a is responsible for prolonged emergence of the rat subjected to sleep deprivation from isoflurane anesthesia. CNS Neurosci Ther. 2015;21(3):298–300.CrossRef
5.
go back to reference Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008;9(5):370–86.CrossRef Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008;9(5):370–86.CrossRef
6.
go back to reference Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437–51.CrossRef Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437–51.CrossRef
7.
go back to reference Kushikata T, Hirota K, Yoshida H, et al. Orexinergic neurons and barbiturate anesthesia. Neurosci. 2003;121(4):855–63.CrossRef Kushikata T, Hirota K, Yoshida H, et al. Orexinergic neurons and barbiturate anesthesia. Neurosci. 2003;121(4):855–63.CrossRef
8.
go back to reference Tang S, Huang W, Lu S, et al. Increased plasma orexin-a levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms. Pept. 2017;88:55–61.CrossRef Tang S, Huang W, Lu S, et al. Increased plasma orexin-a levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms. Pept. 2017;88:55–61.CrossRef
9.
go back to reference Reynolds CF 3rd, O'Hara R. DSM-5 sleep-wake disorders classification: overview for use in clinical practice. Am J Psychiatry. 2013;170(10):1099–101.CrossRef Reynolds CF 3rd, O'Hara R. DSM-5 sleep-wake disorders classification: overview for use in clinical practice. Am J Psychiatry. 2013;170(10):1099–101.CrossRef
10.
go back to reference Zou ZY, Zhao YL, Yang XL, et al. Effects of different remifentanil target concentrations on MAC BAR of sevoflurane in gynaecological patients with CO2 pneumoperitoneum stimulus. Br J Anaesth. 2015;114(4):634–9.CrossRef Zou ZY, Zhao YL, Yang XL, et al. Effects of different remifentanil target concentrations on MAC BAR of sevoflurane in gynaecological patients with CO2 pneumoperitoneum stimulus. Br J Anaesth. 2015;114(4):634–9.CrossRef
11.
go back to reference Wu Y, Jin S, Zhang L, et al. Minimum alveolar concentration-awake of Sevoflurane is decreased in patients with end-stage renal disease. Anesth Analg. 2018;128(1):77–82.CrossRef Wu Y, Jin S, Zhang L, et al. Minimum alveolar concentration-awake of Sevoflurane is decreased in patients with end-stage renal disease. Anesth Analg. 2018;128(1):77–82.CrossRef
12.
go back to reference Bourgeois E, Sabourdin N, Louvet N, et al. Minimal alveolar concentration of sevoflurane inhibiting the reflex pupillary dilatation after noxious stimulation in children and young adults. Br J Anaesth. 2012;108(4):648–54.CrossRef Bourgeois E, Sabourdin N, Louvet N, et al. Minimal alveolar concentration of sevoflurane inhibiting the reflex pupillary dilatation after noxious stimulation in children and young adults. Br J Anaesth. 2012;108(4):648–54.CrossRef
13.
go back to reference Niu B, Fang Y, Miao JM, et al. Minimal alveolar concentration of sevoflurane for induction of isoelectric electroencephalogram in middle-aged adults. Br J Anaesth. 2014;112(1):72–8.CrossRef Niu B, Fang Y, Miao JM, et al. Minimal alveolar concentration of sevoflurane for induction of isoelectric electroencephalogram in middle-aged adults. Br J Anaesth. 2014;112(1):72–8.CrossRef
14.
go back to reference Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiol. 2001;95(6):1362–70.CrossRef Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiol. 2001;95(6):1362–70.CrossRef
15.
go back to reference Katoh T, Ikeda K, Bito H. Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br J Anaesth. 1997;79(4):465–8.CrossRef Katoh T, Ikeda K, Bito H. Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br J Anaesth. 1997;79(4):465–8.CrossRef
16.
go back to reference Quasha AL, Eger EI 2nd, Tinker JH. Determination and applications of MAC. Anesthesiol. 1980;53(4):315–34.CrossRef Quasha AL, Eger EI 2nd, Tinker JH. Determination and applications of MAC. Anesthesiol. 1980;53(4):315–34.CrossRef
17.
go back to reference Hirota K, Kushikata T. Central noradrenergic neurones and the mechanism of general anaesthesia. Br J Anaesth. 2001;87(6):811–3.CrossRef Hirota K, Kushikata T. Central noradrenergic neurones and the mechanism of general anaesthesia. Br J Anaesth. 2001;87(6):811–3.CrossRef
18.
go back to reference Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59(10):1553–62.CrossRef Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59(10):1553–62.CrossRef
19.
go back to reference Sakurai S, Nishijima T, Takahashi S, et al. Low plasma orexin-a levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(3):731–7.CrossRef Sakurai S, Nishijima T, Takahashi S, et al. Low plasma orexin-a levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(3):731–7.CrossRef
20.
go back to reference Dong H, Niu J, Su B, et al. Activation of orexin signal in basal forebrain facilitates the emergence from sevoflurane anesthesia in rat. Neuropeptides. 2009;43(3):179–85.CrossRef Dong H, Niu J, Su B, et al. Activation of orexin signal in basal forebrain facilitates the emergence from sevoflurane anesthesia in rat. Neuropeptides. 2009;43(3):179–85.CrossRef
21.
go back to reference Zhang LN, Li ZJ, Tong L, et al. Orexin-a facilitates emergence from propofol anesthesia in the rat. Anesth Analg. 2012;115(4):789–96.CrossRef Zhang LN, Li ZJ, Tong L, et al. Orexin-a facilitates emergence from propofol anesthesia in the rat. Anesth Analg. 2012;115(4):789–96.CrossRef
22.
go back to reference Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A. 2008;105(4):1309–14.CrossRef Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A. 2008;105(4):1309–14.CrossRef
23.
go back to reference Yasuda Y, Takeda A, Fukuda S, et al. Orexin a elicits arousal electroencephalography without sympathetic cardiovascular activation in isoflurane-anesthetized rats. Anesth Analg. 2003;97(6):1663–6.CrossRef Yasuda Y, Takeda A, Fukuda S, et al. Orexin a elicits arousal electroencephalography without sympathetic cardiovascular activation in isoflurane-anesthetized rats. Anesth Analg. 2003;97(6):1663–6.CrossRef
24.
go back to reference Ouedraogo R, Naslund E, Kirchgessner AL. Glucose regulates the release of orexin-a from the endocrine pancreas. Diabetes. 2003;52(1):111–7.CrossRef Ouedraogo R, Naslund E, Kirchgessner AL. Glucose regulates the release of orexin-a from the endocrine pancreas. Diabetes. 2003;52(1):111–7.CrossRef
25.
go back to reference Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23(1):1–15.CrossRef Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23(1):1–15.CrossRef
26.
go back to reference Taheri S, Mahmoodi M, Opacka-Juffry J, et al. Distribution and quantification of immunoreactive orexin a in rat tissues. FEBS Lett. 1999;457(1):157–61.CrossRef Taheri S, Mahmoodi M, Opacka-Juffry J, et al. Distribution and quantification of immunoreactive orexin a in rat tissues. FEBS Lett. 1999;457(1):157–61.CrossRef
27.
go back to reference Kastin AJ, Akerstrom V. Orexin a but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther. 1999;289(1):219–23.PubMed Kastin AJ, Akerstrom V. Orexin a but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther. 1999;289(1):219–23.PubMed
Metadata
Title
Increased minimum alveolar concentration-awake of Sevoflurane in women of breast surgery with sleep disorders
Authors
Yuanyuan Cao
Lei Zhang
Xiaohui Peng
Yun Wu
Qunlin Zhang
Erwei Gu
Ye Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2020
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-020-0931-3

Other articles of this Issue 1/2020

BMC Anesthesiology 1/2020 Go to the issue